Botulinum toxin-A injections as therapy for chronic painful post-traumatic trigeminal neuropathy: case report

Authors

  • Giancarlo De la Torre Canales Department of Prosthodontics – Bauru School of Dentistry – University of São Paulo – Bauru – Brazil. http://orcid.org/0000-0002-0921-342X
  • Rodrigo Lorenzi Poluha Department of Prosthodontics – Bauru School of Dentistry – University of São Paulo – Bauru – Brazil. https://orcid.org/0000-0001-7180-6448
  • Dyna Mara Ferreira Department of Prosthodontics – Bauru School of Dentistry – University of São Paulo – Bauru – Brazil.
  • Juliana Stuginski-Barbosa Department of Prosthodontics – Bauru School of Dentistry – University of São Paulo – Bauru – Brazil. https://orcid.org/0000-0002-7805-5672
  • Paulo Cesar Rodrigues Conti Department of Prosthodontics – Bauru School of Dentistry – University of São Paulo – Bauru – Brazil. https://orcid.org/0000-0003-0413-4658

DOI:

https://doi.org/10.14295/bds.2020.v23i1.1800

Abstract

Painful post-traumatic trigeminal neuropathy (PTTN) involves spontaneous and evoked pain, of moderate to severe intensity, continuous and described as burning or shooting. The first line treatment is pharmacological. However, botulinum toxin - A (BoNT-A) can be used when medications cannot control pain. This article describes the use of BoNT-A in a case of PTTN refractory to conventional pharmacological treatment. A 44-year-old male patient presented with an 8-years history of pain in the lower left second molar region. Pain was burning, lasting for seconds, with multiple pain episodes per day. Diagnosis hypothesis was PTTN. After no improvement with conventional pharmacological treatment, injections of BoNT-A were elected. Somatosensory assessment showed a significant reduction in visual analog scale for touch, cold and pinprick sensitivity. Likewise, patient's impression of change in pain significantly improved after BoNT-A injections. Our results suggest that BoNT-A could be used as a treatment for PTTN refractory to conventional treatments.

Keywords

Post-traumatic trigeminal neuropathy; Trigeminal neuropathic pain; Botulinum toxin.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2020-01-31

How to Cite

1.
De la Torre Canales G, Poluha RL, Ferreira DM, Stuginski-Barbosa J, Conti PCR. Botulinum toxin-A injections as therapy for chronic painful post-traumatic trigeminal neuropathy: case report. BDS [Internet]. 2020 Jan. 31 [cited 2025 Aug. 21];23(1):5 p. Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/1800

Issue

Vol. 23 No. 1 (2020): Jan. - Mar. - Published Jan. 2020

Section

Case Report or Clinical Technique

License

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.

Most read articles by the same author(s)